Free Trial

Aptevo Therapeutics (APVO) Earnings Date, Estimates & Call Transcripts

Aptevo Therapeutics logo
$4.92 -0.59 (-10.68%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$4.72 -0.20 (-3.96%)
As of 09:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aptevo Therapeutics Earnings Summary

Aptevo Therapeutics released Q1 2025 earnings on May 15, 2025, reporting an EPS of -$4.39, which missed the consensus estimate of -$4.21 by $0.18. With a trailing EPS of $0.00, Aptevo Therapeutics' earnings are expected to grow next year, from ($15.84) to ($14.49) per share.

Q1 2025 Earnings Resources

APVO Upcoming Earnings

Aptevo Therapeutics' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules.

Upcoming Q2
Earnings Date
Aug. 14Before Market OpensEstimated
Consensus EPS
(May. 15)
-$4.21
Actual EPS
(May. 15)
-$4.39 Missed By -$0.18
Get Aptevo Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aptevo Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

APVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aptevo Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$4.21-$4.21-$4.21
Q2 20251-$4.16-$4.16-$4.16
Q3 20251-$3.78-$3.78-$3.78
Q4 20251-$3.74-$3.74-$3.74

Aptevo Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025
(Estimated)
--------
5/15/2025Q1 2025-$4.21-$4.39 -$0.18-$4.39--
8/8/2024--$2,642.17-$2,286.23+$355.94-$1.67--
5/8/2024Q1 2024-$19,302.90-$13,621.55+$5,681.35-$9.95--
11/14/2023Q3 2023-$38,551.04-$30,118.00+$8,433.04-$0.50--
8/10/2023Q2 2023-$67,464.32-$74,090.28 -$6,625.96-$1.23--

Aptevo Therapeutics Earnings - Frequently Asked Questions

Aptevo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on APVO's earnings history.

In the previous quarter, Aptevo Therapeutics (NASDAQ:APVO) missed the analysts' consensus estimate of ($4.21) by $0.18 with a reported earnings per share (EPS) of ($4.39). Learn more on analysts' earnings estimate vs. APVO's actual earnings.

Aptevo Therapeutics (NASDAQ:APVO) has a recorded annual revenue of $3.11 million.

Aptevo Therapeutics (NASDAQ:APVO) has a recorded net income of -$24.13 million. APVO has generated $0.00 earnings per share over the last four quarters.

Aptevo Therapeutics's earnings are expected to grow from ($15.84) per share to ($14.49) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:APVO) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners